Recombinant multi-species CES4A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CES4A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They also participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene, also called CES6, encodes a secreted enzyme, and may play a role in the detoxification of drugs and xenobiotics in neural and other tissues of the body and in the cerebrospinal fluid. Multiple transcript variants encoding different isoforms have been reported, but the full-length nature and/or biological validity of some variants have not been determined. [provided by RefSeq, Jun 2010]
The Alternative Names of target: CES4A,Carboxylesterase 4A,CES6,CES8

Target products collectionGo to CES4A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0760-Ab-1/ GM-Tg-hg-SE0760-Ab-2 Human CES4A protein Human
GM-Tg-rg-SE0760-Ab-1/ GM-Tg-rg-SE0760-Ab-2 Rat CES4A protein Rat
GM-Tg-mg-SE0760-Ab-1/ GM-Tg-mg-SE0760-Ab-2 Mouse CES4A protein Mouse
GM-Tg-cynog-SE0760-Ab-1/ GM-Tg-cynog-SE0760-Ab-2 Cynomolgus/Rhesus macaque CES4A monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0760-Ab-1/ GM-Tg-felg-SE0760-Ab-2 Feline CES4A protein Feline
GM-Tg-cang-SE0760-Ab-1/ GM-Tg-cang-SE0760-Ab-2 Canine CES4A protein Canine
GM-Tg-bovg-SE0760-Ab-1/ GM-Tg-bovg-SE0760-Ab-2 Bovine CES4A protein Bovine
GM-Tg-equg-SE0760-Ab-1/ GM-Tg-equg-SE0760-Ab-2 Equine CES4A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0760-Ab-1/ GM-Tg-hg-SE0760-Ab-2; GM-Tg-rg-SE0760-Ab-1/ GM-Tg-rg-SE0760-Ab-2;
GM-Tg-mg-SE0760-Ab-1/ GM-Tg-mg-SE0760-Ab-2; GM-Tg-cynog-SE0760-Ab-1/ GM-Tg-cynog-SE0760-Ab-2;
GM-Tg-felg-SE0760-Ab-1/ GM-Tg-felg-SE0760-Ab-2; GM-Tg-cang-SE0760-Ab-1/ GM-Tg-cang-SE0760-Ab-2;
GM-Tg-bovg-SE0760-Ab-1/ GM-Tg-bovg-SE0760-Ab-2; GM-Tg-equg-SE0760-Ab-1/ GM-Tg-equg-SE0760-Ab-2
Products Name CES4A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CES4A
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CES4A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.